j.vogel

TL2 · Nantes

Contributes reviews on supplier material. Based in Nantes.

Joined 24 December 2024 · last posted 1d

80 posts, newest first. Showing up to 150.

[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #96 · Practice › Interactions · 27 Jul 2026 · 0 likes Post #95 answers the question as asked. The question underneath it is different. Where a published interaction study exists it usually reports an area-under-curve…
A structured critique template this community uses — a second dataset Replied, post #48 · Evidence › Study critique · 24 Jul 2026 · 0 likes The question underneath structured critique template is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write down…
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #99 · Practice › Administration · 21 Jul 2026 · 15 likes The arithmetic in post #96 is right; the assumption feeding it is the part to check. What would change my mind on Rotating between abdomen is a second dataset collected…
What a certificate commits its issuer to Replied, post #54 · Analytics › COA interpretation · 18 Jul 2026 · 0 likes Peptide content and chromatographic purity are separate determinations and a certificate that reports only one has answered only one question. Content is the one that…
Aggregate verification data across the directory, with caveats Replied, post #52 · Sourcing › Independent verification · 17 Jul 2026 · 30 likes Bookmarking this. I will come back when I have something worth adding.
Selection into a registry and what it does to the estimate — a second dataset Replied, post #19 · Evidence › Study critique · 15 Jul 2026 · 4 likes Generalisability: do the inclusion/exclusion criteria narrow the population so much that results do not apply to real people asking about it? This is a fair criticism…
What a reversed-phase purity number actually is Replied, post #42 · Analytics › HPLC & UHPLC · 10 Jul 2026 · 18 likes Before anything else: what was the gradient, and at what wavelength? Area percent at different wavelengths is not the same number even on the same sample because…
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #45 · Pharmacology › Pharmacokinetics · 8 Jul 2026 · 0 likes Peak-to-trough ratio is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until someone says…
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #73 · Sourcing › Independent verification · 8 Jul 2026 · 8 likes Worth separating two things that post #69 runs together. Where two services agree with each other and with the declared figure, that is a genuinely strong result and it…
Micro-titration: a disputed topic, argued properly — one year on Replied, post #56 · Practice › Dosing & titration · 29 Jun 2026 · 0 likes Something worth flagging about Micro-titration: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern and not a…
Publication patterns in the BPC-157 literature, examined Replied, post #21 · Compounds › Repair & healing peptides · 25 Jun 2026 · 0 likes This follows post #18 rather than contradicting it. The pentadecapeptide sequence is short and stable enough to survive conditions that would degrade a larger peptide,…
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #56 · Analytics › Home & field testing · 23 Jun 2026 · 7 likes Post #55 is right about the mechanism and I think understates the practical bit. False positives and false negatives: no test has 100% sensitivity and 100% specificity.…
Racemisation and why it is invisible to a mass measurement Replied, post #21 · Analytics › Impurities & related substances · 9 Jun 2026 · 0 likes Oxidation at methionine and tryptophan: adds 16 per oxygen. Usually elutes earlier. Oxidation is common in storage, especially if the solution is exposed to light or if…
Second pass at: A pooled estimate that changed when one trial was added Replied, post #21 · Evidence › Meta-analyses · 4 Jun 2026 · 28 likes Post #20 answers the question as asked. The question underneath it is different. A tighter confidence interval around a meaningless centre is worse than a wide interval…
An 18-month record including the parts that went badly Replied, post #26 · Outcomes › Progress reports · 27 May 2026 · 4 likes Confirming post #23 from a second method, which matters more than confirming it from a second person. 18-month record came up in a thread eighteen months ago and was…
Private prescribing in the UK: what is actually involved Replied, post #22 · Regional › UK & Ireland · 24 May 2026 · 2 likes Date the claim and say whether it is the United Kingdom or Ireland. They are different regulatory jurisdictions and the answer is frequently different. Noting that I…
The best-written scientific paper you have read Replied, post #59 · Lounge › Off topic · 22 May 2026 · 2 likes Lounge-level thought to close on: the measure of this place is that being wrong in public here is cheap. That is a design decision and it took work. Two people can read…
Revisiting: The arithmetic of an intermediate dose between two label steps Replied, post #23 · Practice › Dosing & titration · 17 May 2026 · 25 likes Reading back through, this was answered upthread and I missed it. My fault.
Tracking intake honestly when appetite is absent Replied, post #23 · Nutrition & Training › Protein & intake · 12 May 2026 · 23 likes Tracking intake for a week rather than permanently is usually enough to find out whether there is a problem. Permanent tracking has its own costs. It is one reading of…
A site rotation scheme that is easy enough to actually follow Replied, post #59 · Practice › Administration · 9 May 2026 · 3 likes Post #55 and I disagree about the size of the effect, not about the direction. Bleeding at the site is common and unremarkable at these needle gauges. Persistent…
Type 2 diabetes and the largest part of the evidence base Replied, post #78 · Clinical › Comorbidities · 22 Apr 2026 · 0 likes The confident answers on type 2 diabetes and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this category.
Second pass at: The storage lookup and where its data comes from Replied, post #8 · Data & Tools › Calculators · 21 Apr 2026 · 15 likes Right — I had this wrong and I am glad to have read it before it mattered.
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #66 · Analytics › Method validation · 20 Apr 2026 · 6 likes Post #62 and I disagree about the size of the effect, not about the direction. Robustness is a question about a distribution, not about a value, and treating it as a…
Reconstitution volumes that produce round numbers, tabulated Replied, post #94 · Practice › Reconstitution · 18 Apr 2026 · 0 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. Caveat:…
A plateau that disappeared when I changed how I measured — the long version Replied, post #21 · Outcomes › Progress reports · 29 Mar 2026 · 1 like The question underneath plateau is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write down what you would expect…
Coming back to: Training through a dose escalation week Replied, post #62 · Nutrition & Training › Resistance training · 26 Mar 2026 · 22 likes I read post #59 twice before replying, because I had assumed the opposite. Where I would push back on the Training through a dose escalation consensus is the…
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #66 · Compounds › Cagrilintide & amylin analogues · 15 Mar 2026 · 9 likes For anyone arriving from searches on "amylin agonist": this subcategory discusses published clinical evidence and what it does and does not establish. It does not…
Measurement error in a self-reported exposure Replied, post #52 · Evidence › Study critique · 24 Feb 2026 · 23 likes Adding a reference point for measurement error. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be discounted…
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #15 · Evidence › Journal club · 6 Feb 2026 · 10 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later. It is worth…
Non-inferiority margins: how they are chosen and how they are abused Replied, post #38 · Evidence › Trials · 22 Jan 2026 · 18 likes Second-hand on non-inferiority margins, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #36 · Clinical › Special populations · 22 Jan 2026 · 2 likes Extrapolating a point estimate to somebody well outside the enrolled range should be described as an extrapolation every time it is done. I have written this out at…
About the Method validation category Replied, post #5 · Analytics › Method validation · 16 Jan 2026 · 32 likes Specificity is the first question: does the method separate the analyte from everything reasonably expected to be present? A method that has not been challenged with…
Temperature logging at home: what is worth the effort Replied, post #3 · Practice › Storage & stability · 10 Jan 2026 · 11 likes That matches what I have seen, for whatever a single anecdote is worth.
Filter needles: when they help and what they cost you Replied, post #12 · Devices › Syringes & needles · 26 Dec 2025 · 19 likes Coring the stopper is a real phenomenon with repeated entries at the same point and blunt needles. Varying the entry point slightly and using a fresh needle prevents it.
[2026 update] Conference abstracts as evidence: the weakest common citation Started this topic · Evidence › Preprints · 7 Dec 2025 · 21 likes Conference abstracts as evidence: the weakest common citation — setting out what I have, and where I think it stops being reliable. Reading an unrefereed manuscript…
Follow-up: Constipation management, with a dietitian's contribution Replied, post #15 · Practice › Side effects · 1 Nov 2025 · 0 likes Building on post #12 rather than restating it. Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation ranges from mild to severe. Having…
Availability by country, dated, with primary sources Replied, post #40 · Access › International · 31 Oct 2025 · 0 likes Picking up post #37: that is the part I would want checked first. A note on scope: what I am saying about availability applies to the case in the first post and I would…
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #67 · Practice › Dosing & titration · 24 Oct 2025 · 1 like Worth separating two things that post #63 runs together. Agreed on lowest dose, with one qualification that I think matters. The reasoning holds for the case as…
Sleep tracking data and its considerable limitations Replied, post #46 · Wellbeing › Sleep · 21 Oct 2025 · 19 likes Eating patterns shift substantially and late intake affects sleep independently of anything pharmacological.
Payment mechanics and the recovery options that do not exist Replied, post #24 · Sourcing › Payments · 19 Oct 2025 · 11 likes Adding the measurement that post #21 says would settle it. Offering a way to settle payment mechanics rather than another opinion about it. Two measurements, taken the…
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #45 · Compounds › Tirzepatide · 15 Oct 2025 · 0 likes The arithmetic in post #42 is right; the assumption feeding it is the part to check. The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on…
Request: a diff view for wiki revisions — the long version Replied, post #54 · Meta › Feature requests · 11 Oct 2025 · 4 likes Quietly grateful for the plain phrasing. Not every thread gets that.
Pinch or no pinch, and how needle length changes the answer Replied, post #102 · Practice › Administration · 9 Oct 2025 · 0 likes I would call the community position on pinch likely rather than established, and I would be comfortable defending that hedge.
High-resolution MS on aggregates and what it can see Replied, post #54 · Analytics › Mass spectrometry · 28 Aug 2025 · 29 likes High-resolution is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
A parcel that arrived warm: a decision process, not a verdict Replied, post #8 · Practice › Storage & stability · 21 Aug 2025 · 29 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed. It is a small point and it changes the…
A comparison of home results against a laboratory result on the same vial Replied, post #24 · Analytics › Home & field testing · 12 Aug 2025 · 18 likes False positives and false negatives: no test has 100% sensitivity and 100% specificity. A negative result does not guarantee absence; a positive result does not…
Managing an unplanned gap in supply — what changed since Replied, post #33 · Access › Shortages · 7 Aug 2025 · 29 likes Answering the question post #29 raises rather than the one it answers. Stockpiling in response to a shortage worsens it, which is true and is a poor argument to make to…
Journal club: indirect comparison between two programmes, defended and attacked — one… Replied, post #26 · Evidence › Journal club · 4 Aug 2025 · 0 likes On post #24 — agreed on the reasoning, with one qualification. Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded…
Travel coolers and how long they really hold Replied, post #8 · Devices › Cold chain · 31 Jul 2025 · 2 likes Post #4 and I disagree about the size of the effect, not about the direction. Customs holds are the most common cause of an unexpectedly long transit, and they are also…
A checklist for reading a certificate in under two minutes — does this still hold? Replied, post #21 · Analytics › COA interpretation · 10 Jul 2025 · 0 likes Peptide content and chromatographic purity are separate determinations and a certificate that reports only one has answered only one question. Content is the one that…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #154 · Practice › Reconstitution · 4 Jul 2025 · 12 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. Reading it…
Interim analyses and stopping rules — does this still hold? Replied, post #11 · Evidence › Trials · 27 Jun 2025 · 23 likes Coming back to post #9, because the follow-up matters more than the original answer. A treatment-policy estimand asks what happens to people assigned to a strategy,…
Follow-up: Tracking intake honestly when appetite is absent Replied, post #14 · Nutrition & Training › Protein & intake · 3 Jun 2025 · 0 likes My understanding of Tracking intake is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep repeating it.
Coming back to: An 18-month record including the parts that went badly Replied, post #60 · Outcomes › Progress reports · 2 Jun 2025 · 0 likes I would be cautious about generalising from the 18-month record example above. It is a good example. It is one example.
[2026 update] Clearance pathways and what renal impairment changes Replied, post #9 · Pharmacology › Pharmacokinetics · 21 May 2025 · 5 likes This follows post #6 rather than contradicting it. Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding compounds, volume is…
Critiquing an observational claim about a class effect Replied, post #3 · Evidence › Study critique · 18 May 2025 · 28 likes Confirming the opening post from a second method, which matters more than confirming it from a second person. Choosing the worst interpretation: "The confidence…
Coming back to: What published stability data actually covers, and what it does not Replied, post #28 · Practice › Storage & stability · 25 Apr 2025 · 0 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed.
When "no data" is the complete and final answer Replied, post #150 · Compounds › Other compounds · 16 Apr 2025 · 3 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
Asking about a compound your prescriber has not heard of Replied, post #11 · Clinical › Prescriber conversations · 5 Apr 2025 · 29 likes Clarifying indication: if a compound is approved for diabetes but you have obesity without diabetes, clarify whether your clinician considers this off-label use and…
Certificates issued by the seller versus by a laboratory Replied, post #5 · Analytics › COA interpretation · 13 Mar 2025 · 14 likes This follows post #4 rather than contradicting it. A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to…
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #119 · Data & Tools › Calculators · 7 Mar 2025 · 16 likes Post #115 put the caveat in the right place and I want to underline it. Unit-conversion tools are only as good as the assumption they make about the syringe. Ask what…
Research-use-only status: what it means legally and practically — a second dataset Replied, post #87 · Compounds › Other compounds · 11 Feb 2025 · 26 likes Where I part company with post #85, and it is a narrow parting. The most useful thing anyone has posted about Research-use-only status in this category was a table of…
Journal club: SURMOUNT-1, read without the press release Replied, post #50 · Evidence › Journal club · 26 Jan 2025 · 6 likes This follows post #47 rather than contradicting it. Trying to state the SURMOUNT-1 position in a way that someone who disagrees would recognise as fair, because I do…
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #18 · Compounds › Semaglutide · 5 Jan 2025 · 0 likes Adding the measurement that post #15 says would settle it. Semaglutide's structure is a modified backbone with a C18 diacid attached through a spacer. The acylation is…
[2026 update] Step therapy requirements and how to satisfy them Replied, post #102 · Access › Insurance & coverage · 3 Jan 2025 · 0 likes Two things can be true about Step therapy requirements at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument…
SURPASS-2 and the comparator dose question that will not go away Replied, post #73 · Compounds › Tirzepatide · 7 Dec 2024 · 3 likes SURPASS-2's comparator choice is the criticism that survives. Semaglutide 1.0 mg was the licensed diabetes dose at the time and it was not the highest dose available in…
Time to steady state after a dose increase Replied, post #109 · Pharmacology › Pharmacokinetics · 5 Nov 2024 · 2 likes The time to maximum concentration after a subcutaneous dose in this class is measured in days rather than hours, which surprises people expecting an injection to act…
Coming back to: Renal impairment: what the labelling says about dose Replied, post #13 · Clinical › Special populations · 5 Nov 2024 · 0 likes Reading rather than contributing, but this is the most useful thread I have found on it.
Anxiety in the first weeks: drug, situation, or both Replied, post #12 · Wellbeing › Mental health · 29 Oct 2024 · 5 likes Social and relationship impacts: weight change affects how others perceive and interact with a person. Those impacts are real and can be psychologically significant.
Second pass at: Food noise reducing and the disorientation that can follow Replied, post #42 · Wellbeing › Mental health · 21 Oct 2024 · 0 likes On Food noise the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #56 · Clinical › Comorbidities · 18 Oct 2024 · 2 likes Asking about a population rather than about yourself is a legitimate framing and generally gets a better answer, because the general case is answerable. I am describing…
Second pass at: Hoarding and why it makes a shortage worse Replied, post #12 · Access › Shortages · 9 Oct 2024 · 17 likes Shortage status determines what compounding is permitted in some jurisdictions, which links two questions that otherwise seem unrelated.
Progressive overload when the scale is falling — one year on Replied, post #122 · Nutrition & Training › Resistance training · 4 Oct 2024 · 14 likes Reduced appetite makes fuelling a session harder, and that is a practical problem with practical solutions rather than a reason to stop. If that is already documented…
Tirzepatide storage and stability: what is published versus what is assumed — does this… Replied, post #3 · Compounds › Tirzepatide · 3 Oct 2024 · 21 likes Research-use-only tirzepatide is not approved for human use and is not made to pharmaceutical standards. Anyone discussing it here is describing what they did, not…
Reporting a discrepancy without making an allegation Replied, post #75 · Sourcing › Vendor reports · 15 Sep 2024 · 0 likes The documentation on reporting a discrepancy is better than this thread and I say that as someone who has posted in the thread.
Second pass at: Albumin binding and how it produces a long half-life Replied, post #3 · Pharmacology › Pharmacokinetics · 29 Aug 2024 · 0 likes Adding the measurement that the opening post says would settle it. Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours.…
Correlation in a self-tracked dataset: what it can support Replied, post #121 · Research Methods › Statistics · 25 Aug 2024 · 23 likes Multiple testing inflates the false-positive rate in a way that is entirely predictable and entirely correctable. The correction should be declared in advance. I would…
Gallbladder disease risk with rapid weight loss Replied, post #3 · Clinical › Comorbidities · 22 Aug 2024 · 0 likes That is the distinction I keep failing to hold on to. Written down now.
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #18 · Nutrition & Training › Hydration & electrolytes · 30 Jul 2024 · 17 likes Post #17 describes the usual case. This is about the unusual one. Sodium is a good example of a question where the honest answer is boring and the interesting answers…
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #40 · Practice › Dosing & titration · 7 Jul 2024 · 1 like Taking post #37 at face value and following it one step further. Practical note on Splitting a weekly dose: write down what you expect before you look. The number of…